. Author manuscript; available in PMC: 2024 May 1.

Published in final edited form as: Lancet Diabetes Endocrinol. 2023 Mar 31;11(5):345–361. doi: 10.1016/S2213-8587(23)00038-4

Table 1.

PET radiopharmaceuticals	Pitfalls

SSTR analogs	Uncinate process Stellate ganglia Splenunculi (accessory spleens), splenosis Pancreatic heterotopia Pancreatic serous cystadenoma Bone hemangioma, enchondroma, fibrous dysplasia Active chronic inflammation (e.g., sarcoidosis, tuberculosis, Hashimoto's thyroiditis) Other tumors (e.g., meningioma, breast cancer, renal cancer, lymphoma, thyroid neoplasms, glioma, neuroblastoma)

¹⁸F-FDOPA	Solid pseudopapillary tumor of the pancreas Thyroid neoplasm Pituitary adenoma Squamous cell carcinoma Poorly differentiated adenocarcinoma Melanoma Multiple myeloma Hepatocellular carcinoma Schwannoma Chondrosarcoma